Andrew Bellantoni, MD
Pediatric Hematology-Oncology · Hawthorne, NYNPI 1003278680
Payments from drug & device makers
Across 42 payments — averaging $475.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$19K
- Novartis$388
- Y-mabs Therapeutics, Inc.$123
- Jazz Pharmaceuticals Inc.$121
- Servier Pharmaceuticals LLC$111
- CSL Behring$64
- plus $314 from 10 others
What the payments were for
- Food & beverage$1,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 2 | $18,831 |
| Novartis | 15 | $388 |
| Y-mabs Therapeutics, Inc. | 1 | $123 |
| Jazz Pharmaceuticals Inc. | 1 | $121 |
| Servier Pharmaceuticals LLC | 5 | $111 |
| CSL Behring | 3 | $64 |
| Sobi, Inc | 3 | $63 |
| Amgen | 3 | $58 |
| Pfizer | 2 | $39 |
| USWM, LLC | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Biocon Biologics Inc | 1 | $23 |
| Gilead | 1 | $22 |
| Bio Products Laboratory USA, Inc. | 1 | $20 |
| RARE Disease Therapeutics, Inc. | 1 | $18 |
| Tempus AI, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,952 in reported general payments places this provider in the 55th percentile of 196 pediatric hematology-oncology providers in New York.
See all pediatric hematology-oncology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric hematology-oncology in Hawthorne
- Mitchell CairoHawthorne$9.8M
- Jennifer KrajewskiHawthorne$103K
- Lewis SilvermanNew York$33.2M
- Jamie FlerlageRochester$20.1M
- Monica BhatiaNew York$7M
- Francine BleiNew York$5.3M
- John LevineNew York$5.1M
- Jaap Jan BoelensNew York$2.5M
- Matthias KarajannisNew York$2.1M
- Nai-Kong CheungNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.